TABLE 1

Midazolam population pharmacokinetic parameters


Model Parametera

Population Estimate (SEE)

Intersubject Variability (SEE)

Within-Subject Variability (SEE)
Ka (h-1) 1.3 (7.55) 54.9 (23) 38.6 (43)
F2 (oral solution) 0.32 (4.2) 34.4 (21) 16.9 (35)
F1 (tablet) 0.603 (12.4)
CLint (l/h) 63.8 (12) 77.8 (24) 19.9 (62)
Effect of Age on CLintb -7.51 (58)
Vc (liters) 38 (7.0) 35.9 (62) 52 (29)
Vp (líters) 18.7 (24) 43.1 (20)
Effect of Weight on Vpc 1 (22)
Vt (liters) 101 (16)
Effect of Sex on Vtd -0.318 (44)
Q1 (l/h) 97.2 (11)
Q2 (l/h)
13.5 (12)


Covariance between CLint and Vc

0.239 (35)
Residual errors
Proportional error of i.v. 21.0 (% CV)
Additive error for i.v. 0.0468 ng/ml
Proportional error for oral

35.2 (% CV)
  • SEE, standard error of the estimate in %; —, not estimated.

  • a The three-compartment population model (Kramer et al., 1974) was described by a series of differential equations parameterized in terms of Ka, first-order absorption rate constant; Vc, central volume of distribution; Vp and Vt, peripheral volumes of distribution; Q1 and Q2, distributional clearance = intercompartmental flow constant × volume of input compartment; CLint, intrinsic clearance.

  • b CLint = population CLint - 7.51 · (age/32); CL = Qh · CLint/(Qh + CLint).

  • c Vp = population Vp · EXP(body weight/72).

  • d Vt = population Vt · (1 -0.318 · Sex); female = 0, male = 1.